Acadian Asset Management
TNYA icon

Acadian Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Acadian Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
203,150
+33,370
+20% +$25.3K ﹤0.01% 1685
2026
Q1 		$116K Buy
+169,780
New +$125K ﹤0.01% 1712
2025
Q2 		– Sell
-30,173
Closed -$17K – 1836
2025
Q1 		$17K Buy
+30,173
New +$29.8K ﹤0.01% 1543
2024
Q4 		– Sell
-12,564
Closed -$24K – 2163
2024
Q3 		$24K Buy
12,564
+702
+6% +$1.98K ﹤0.01% 1954
2024
Q2 		$36K Sell
11,862
-167,270
-93% -$691K ﹤0.01% 1634
2024
Q1 		$936K Sell
179,132
-115,373
-39% -$552K ﹤0.01% 861
2023
Q4 		$952K Buy
294,505
+190,436
+183% +$411K ﹤0.01% 874
2023
Q3 		$263K Buy
104,069
+86,769
+502% +$363K ﹤0.01% 1150
2023
Q2 		$101K Sell
17,300
-11,620
-40% -$67.5K ﹤0.01% 1400
2023
Q1 		$81K Buy
+28,920
New +$81.3K ﹤0.01% 1435

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's TNYA Position: Q2 2026 in Review

Acadian Asset Management increased its Tenaya Therapeutics (TNYA) stake by 20% in Q2 2026, buying an estimated $25.3K and bringing the position to 203,150 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Acadian Asset Management first reported a position in TNYA in Q1 2023 and has held it in 10 quarters since. The position peaked at $952K in Q4 2023. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Acadian Asset Management held 203,150 shares of Tenaya Therapeutics worth $148K as of Q2 2026.
  • Acadian Asset Management bought 33,370 Tenaya Therapeutics shares in Q2 2026, an estimated $25.3K.
  • Tenaya Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1685 holding.
  • Acadian Asset Management first reported a position in Tenaya Therapeutics in Q1 2023 and has held it in 10 quarters since.
  • Acadian Asset Management's Tenaya Therapeutics position peaked at $952K in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.